ILIKA PLC — Regulatory Filings 2017

Mar 14, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3157Z

Ilika plc

14 March 2017

Ilika plc

("Ilika" or the "Company")

Ilika and Galvani Bioelectronics enter into collaboration in Bioelectronics Project

Ilika (AIM: IKA), a pioneer in materials innovation and solid-state battery technology, announces a two-year collaborative project with Galvani Bioelectronics to develop a solid state battery for miniature medical implants. Ilika's StereaxTM batteries have a high power density, a long battery life and they can be produced in miniature form, making them particularly suitable for these micro-devices.

This collaboration aims to deliver key components of bioelectronic devices, which have the potential to provide treatments for serious health conditions, through the body's own nervous system.

The £1.0 million development project is supported by funding of £0.7 million, which Ilika will receive from Innovate UK and the Medical Research Council.

Commenting on this grant award, Graeme Purdy, Ilika CEO, said: "This partnership with Galvani Bioelectronics, using Ilika's lithium-ion Stereax battery technology, may provide the potential to treat diseases that have so far been difficult to manage. Collaborations like this are critical to the delivery of advances in the field of solid state battery development."

For more information, contact:

# Ilika plc	# www.ilika.com
# Graeme Purdy, Chief Executive	# Tel: 023 8011 1400
# Steve Boydell, Finance Director
# Numis Securities Limited	# Tel: 020 7260 1000
# Oliver Cardigan/ Paul Gillam /
# James Black
# Walbrook PR Ltd	# Tel: 020 7933 8780 / ilika@walbrookpr.com
# Paul Cornelius	# Mob: 07866 384 707
# Lianne Cawthorne	# Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCJJMFTMBMBBFR